not long now, page-5

Hi, archbald,

In the 2005 annual report, OBJ stated that it was in early stage discussion with major pharmaceutical companies. Mr. Edwards talked about doing one or two deal in 2006 calendar year in the Board Room Radio interview in April (please correct me if I am wrong). I personally assume that the talks with pharmas are ongoing. In April this year, OBJ announced that its drug delivery technology had been proven in human trial -- this could be a big, big plus for OBJ when talking to a pharma? I, as a shareholder, am certainly hoping for a pharma deal announcement.

In this year’s annual report, OBJ just broadly mentioned about cosmetic front actives. Unlike in 2005, BECCA jv was not discussed. I would assume not much progress has been made in term of bringing revenues. Otherwise, an announcement regarding the jv would have been made to ASX, I would like to think? Still, want to hear an update on this issue.

please DYOR